Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

被引:1
|
作者
Tanaka, John [1 ]
Young, Rebecca [2 ]
Spees, Lisa [3 ]
Jenkins, Kirsten [2 ]
Sung, Anthony D. [4 ]
Martin, Paul L. [5 ]
Heston, Sarah [2 ]
Thompson, Jillian C. [4 ]
Seed, Patrick [6 ]
Arshad, Mehreen [6 ]
Kelly, Matthew [2 ]
机构
[1] Duke Univ, Sch Med, Durham, NC USA
[2] Duke Univ, Med Ctr, Div Pediat Infect Dis, Durham, NC USA
[3] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA
[4] Duke Univ, Med Ctr, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA
[5] Duke Univ, Med Ctr, Div Pediat Blood & Marrow Transplant, Durham, NC USA
[6] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Infect Dis, Chicago, IL 60611 USA
关键词
D O I
10.1182/blood-2019-125080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1992
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
    Toubai, Tomomi
    Paczesny, Sophie
    Shono, Yusuke
    Tanaka, Junji
    Lowler, Kathleen P.
    Malter, Chelsea T.
    Kasai, Masaharu
    Imamura, Masahiro
    CURRENT STEM CELL RESEARCH & THERAPY, 2009, 4 (04) : 252 - 259
  • [42] Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    P Reddy
    K Johnson
    J P Uberti
    C Reynolds
    S Silver
    L Ayash
    T M Braun
    V Ratanatharathorn
    Bone Marrow Transplantation, 2006, 38 : 351 - 357
  • [43] Graft-Versus-Host Disease of the Lung after Allogeneic Hematopoietic Stem Cell Transplantation - A Report of Two Cases
    Roh, Ji Hyeon
    Han, Joungho
    Yoo, Keon-Hee
    Ahn, Kang-Mo
    Kim, Jihye
    KOREAN JOURNAL OF PATHOLOGY, 2009, 43 (04) : 378 - 381
  • [44] Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Weissinger, Eva M.
    Schiffer, Eric
    Hertenstein, Bernd
    Ferrara, James L.
    Holler, Ernst
    Stadler, Michael
    Kolb, Hans-Jochem
    Zander, Axel
    Zurbig, Petra
    Kellmann, Markus
    Ganser, Arnold
    BLOOD, 2007, 109 (12) : 5511 - 5519
  • [45] Association Between MDSCs and Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Qifa, Sr.
    Ling, Yiwen
    Fan, Zhiping
    Zhang, Yu
    Huang, Fen
    Wu, Xiuli
    Xuan, Li
    Wu, Meiqing
    BLOOD, 2011, 118 (21) : 1737 - 1738
  • [46] Sleep Quality in Patients With Ocular Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Liao, Yinglin
    Li, Jing
    Yang, Jing
    Zhao, Wenxin
    Chen, Ziyan
    Wu, Shaowen
    Jin, Ling
    Huang, Fen
    Liang, Lingyi
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2024, 50 (03): : 145 - 151
  • [47] Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease
    Yanez, L.
    Insunza, A.
    Ibarrondo, P.
    de Miguel, C.
    Bermudez, A.
    Colorado, M.
    Lopez-Duarte, M.
    Richard, C.
    Conde, E.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (05) : 761 - 767
  • [48] MINOR HISTOCOMPATIBILITY ANTIGENS AS DETERMINANTS FOR GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Turpeinen, Hannu
    Ojala, Pauli
    Volin, Liisa
    Partanen, Jukka
    TISSUE ANTIGENS, 2012, 79 (06): : 461 - 462
  • [49] Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Zupan, IP
    Zver, S
    Pretnar, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2931 - 2933
  • [50] Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Servais, Sophie
    Beguin, Yves
    Delens, Loic
    Ehx, Gregory
    Fransolet, Gilles
    Hannon, Muriel
    Willems, Evelyne
    Humblet-Baron, Stephanie
    Belle, Ludovic
    Baron, Frederic
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 957 - 972